BNTC
Benitec Biopharma Inc
NASDAQ · Biotechnology
$12.12
+0.47 (+4.03%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 792.56M | 838.23M | 726.24M |
| Net Income | 29.18M | 25.09M | 21.12M |
| EPS | — | — | — |
| Profit Margin | 3.7% | 3.0% | 2.9% |
| Rev Growth | +7.9% | +14.3% | -7.3% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 36.97M | 45.09M | 45.44M |
| Total Equity | 251.07M | 287.18M | 287.83M |
| D/E Ratio | 0.15 | 0.16 | 0.16 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 33.32M | 33.92M | 33.30M |
| Free Cash Flow | 24.79M | 28.65M | 30.31M |